NMF
  • Menu Canvas
    • NMF
      • Nikki Mitchell Foundation
      • Nikki Mitchell
        • Bridge of Wings Flight
        • Documentary
      • Financials and Board
      • Contact Us
    • Programs
      • Bridge of Wings
      • Hope Suite Hope
    • Pancreatic Cancer
      • Statistics & Risk Factors
      • Research & Detection
        • Seed Grant Awardees
    • Inspiration
      • Volunteers
      • Warriors
    • Events
      • Previous Event Photos
    • News
    • Donate
    • NMF
      • Nikki Mitchell Foundation
      • Financials and Board
      • Nikki Mitchell
      • Contact
    • Pancreatic Cancer
      • Statistics & Risk Factors
      • Research & Detection
    • Programs
      • Bridge of Wings
      • Hope Suite Hope
    • Inspiration
      • Warriors
      • Volunteers
    • Events
    • News
NMF
  • NMF
    • Nikki Mitchell Foundation
    • Nikki Mitchell
      • Bridge of Wings Flight
      • Documentary
    • Financials and Board
    • Contact Us
  • Programs
    • Bridge of Wings
    • Hope Suite Hope
  • Pancreatic Cancer
    • Statistics & Risk Factors
    • Research & Detection
      • Seed Grant Awardees
  • Inspiration
    • Volunteers
    • Warriors
  • Events
    • Previous Event Photos
  • News
  • Donate

Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy

Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy

Christa Bowles
October 15, 2018
Uncategorized
Image credit: Zaky, AM, Wolfgang, CL, Weiss, MJ, et al. (2016). Tumor-vessel relationships in pancreatic ductal adenocarcinoma at multidetector CT: different classification systems and their influence on treatment planning. RadioGraphics; 37(1):93-112

The following study was recently published in the Journal of Gastrointestinal Surgery by Ammar A. Javed and colleagues in September 2018. Below is a summary of the article.

Localized pancreatic cancer can be classified into resectable, borderline resectable and locally advanced lesions based on the degree of involvement of adjacent blood vessels (portal vein, superior mesenteric artery and celiac artery). Borderline resectable tumors are those that have limited invasion of the vessels and, while surgically resectable, carry a high risk of positive margins at the time of resection (see prior Nikki Mitchell Foundation article on margin status). Chemotherapy available for pancreatic cancer has improved significantly over the last decade. With effective therapies now available, a majority of patients with borderline resectable disease now receive preoperative chemotherapy. The authors sought to evaluate the outcomes of patients undergoing surgery for borderline resectable pancreatic cancer at a single high-volume center.

The authors identified 151 patients from their multidisciplinary clinic who were diagnosed with borderline resectable pancreatic cancer. 142 (94.0%) patients received chemotherapy and 78 (51.7%) received radiation therapy. Ninety-six (63.6%) were able to undergo surgery, while 12 (7.9%) patients were taken to the operating room but their procedure was aborted due to extensive disease. 47 (31.1%) of patients unfortunately had progression of disease and were deemed to be unresectable at follow up. Patients who underwent surgery had a median overall survival of 28.8 months as compared to 13.5 months in those who did not receive surgery.

Take home points:

  • Multidisciplinary management is vital for borderline resectable pancreatic cancer.
  • Resection of borderline resectable pancreatic cancer is safe when performed by experienced surgeons at a high volume institution.
  • The rate of resection in patients with borderline pancreatic cancer is approximately 65%.
  • Surgical resection of borderline resectable pancreatic cancer is associated with improved overall survival.
  • Disease progression while receiving chemotherapy is the most frequent reason for unresectability.

You can read the entire article here.

A special thanks for this summary by Michael Wright, Department of Surgery, Johns Hopkins School of Medicine and Dr. Ammar Javed for his support.

Previous Story
The 7th Annual Jamey Johnson Golf Tournament Raises $421,500 to Fight Pancreatic Cancer
Next Story
NMF Friends Raise $5,000 from Normandy, TN Event

Related Articles

Music Leader Shannan Hatch Joins Nikki Mitchell Foundation Board

Nashville, TN –SESAC Pro Vice President Shannan Hatch has been...

Your Dollars at Work

Nikki Mitchell Foundation is a relatively young non-profit. In the...

Recent Posts

  • Music Leader Shannan Hatch Joins Nikki Mitchell Foundation Board Wednesday, 30, Mar
  • Your Dollars at Work Thursday, 27, Jan
  • 2021 Impact Report Monday, 24, Jan
  • 2021 Nikki Mitchell Foundation Seed Grant Winner Monday, 22, Nov
  • A Surviving Story Thursday, 17, Jun

Contact Us

1-615-982-6802
PO Box 68305 Nashville, TN 37206
[email protected]
EIN Tax ID: 46-3399632

Join Our Mailing List

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Nikki Mitchell Foundation, PO Box 68305, Nashville, TN, 37206, http://www.nikkimitchellfoundation.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Follow Us

Contact Us

1-615-982-6802
PO Box 68305 Nashville, TN 37206
[email protected]
EIN Tax ID: 46-3399632
Copyright ©2020 Nikki Mitchell Foundation. All Rights Reserved. Nikki Mitchell Foundation is a registered 501(c)(3) non-profit.

Medical Disclaimer:
Information is solely intended as educational purpose only. It is not to be considered as a substitute for professional medical advice. We encourage all visitors to consult directly with their physician. Site visitors should not rely on any information contained for health needs. Instead, all questions should be discussed with professional medical doctors.
SearchPostsLogin
Wednesday, 30, Mar
Music Leader Shannan Hatch Joins Nikki Mitchell Foundation Board
Thursday, 27, Jan
Your Dollars at Work
Monday, 24, Jan
2021 Impact Report
Monday, 22, Nov
2021 Nikki Mitchell Foundation Seed Grant Winner
Thursday, 17, Jun
A Surviving Story
Monday, 24, May
Clinical Trials

Welcome back,